Temelastine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H24BrN5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BF6IGI53XH, chemically known as 4(1h)-pyrimidinone, 2-((4-(5-bromo-3-methyl-2-pyridinyl)butyl)amino)-5-((6-methyl-3-pyridinyl)methyl)- but generally known as temelastine, which bears US NIH Compound Identifier 55482. European Medicines Agency schedules Temelastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10882MIG. The term TEMELASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). TEMELASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule temelastine under HS 29335995 and SITC 51576. As of Q4 2014, TEMELASTINE remains the US FDA Preferred Term for this commodity. Temelastine bears US NLM identifiers UMLS ID C0076078 and NCI Concept Code C73058. SMILES: BRC1CC(C(NC1)CCCCNC1[NH]C(=O)C(CC2CCC(NC2)C)CN1)C.